Image

Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study

Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This multicenter retrospective study aims to evaluate the diagnostic and therapeutic performance of three large language models-ChatGPT, Gemini and Deepseek-using 800 archived inpatient medical records from urology departments across four tertiary hospitals. The study will focus on the accuracy and applicability of these models in disease recognition, preliminary diagnosis and treatment recommendation generation, in order to explore their potential value and limitations in supporting clinical decision-making in real-world settings.

Eligibility

Inclusion Criteria:

  • The case data is sourced from the four hospitals involved in the study, with complete and authentic diagnosis and treatment records.
  • Patients must be 18 years or older, with no gender restrictions.
  • Complete medical records, including the following core information: patient' s basic information, present illness history, past medical history, physical examination, and auxiliary examinations (including laboratory and imaging tests).
  • A clear discharge diagnosis and treatment plan (including therapeutic measures and follow-up arrangements).
  • Medical records have been archived, with objective and accurate information that has not been altered.
  • The patient or their legal representative has provided informed consent, agreeing to the use of their anonymized medical data for research analysis.

Exclusion Criteria:

  • Medical records with significant missing information, such as key clinical details (present illness history, diagnostic or treatment records, etc.).
  • Cases where the diagnosis or treatment plan is unclear, or where treatment has not been fully completed for an initial diagnosis.
  • Cases where the primary diagnosis is not urological.
  • Cases with major errors or inconsistencies in the records that could affect further assessment.
  • Medical records in special formats or images that are not readable (e.g., handwritten notes, non-standard documentation).
  • Patients who have not signed the informed consent form or who refuse to allow their medical data to be used for research.

Study details
    Urologic Diseases

NCT07378358

First Affiliated Hospital of Fujian Medical University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.